1. Home
  2. ALLO vs HFFG Comparison

ALLO vs HFFG Comparison

Compare ALLO & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • HFFG
  • Stock Information
  • Founded
  • ALLO 2017
  • HFFG 1997
  • Country
  • ALLO United States
  • HFFG United States
  • Employees
  • ALLO N/A
  • HFFG N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • HFFG Food Distributors
  • Sector
  • ALLO Health Care
  • HFFG Consumer Discretionary
  • Exchange
  • ALLO Nasdaq
  • HFFG Nasdaq
  • Market Cap
  • ALLO 231.9M
  • HFFG 208.3M
  • IPO Year
  • ALLO 2018
  • HFFG N/A
  • Fundamental
  • Price
  • ALLO $1.05
  • HFFG $3.48
  • Analyst Decision
  • ALLO Strong Buy
  • HFFG
  • Analyst Count
  • ALLO 10
  • HFFG 0
  • Target Price
  • ALLO $8.88
  • HFFG N/A
  • AVG Volume (30 Days)
  • ALLO 5.8M
  • HFFG 96.4K
  • Earning Date
  • ALLO 08-13-2025
  • HFFG 08-11-2025
  • Dividend Yield
  • ALLO N/A
  • HFFG N/A
  • EPS Growth
  • ALLO N/A
  • HFFG N/A
  • EPS
  • ALLO N/A
  • HFFG N/A
  • Revenue
  • ALLO N/A
  • HFFG $1,216,952,000.00
  • Revenue This Year
  • ALLO N/A
  • HFFG $4.27
  • Revenue Next Year
  • ALLO $199.63
  • HFFG $4.47
  • P/E Ratio
  • ALLO N/A
  • HFFG N/A
  • Revenue Growth
  • ALLO N/A
  • HFFG 4.88
  • 52 Week Low
  • ALLO $0.86
  • HFFG $1.70
  • 52 Week High
  • ALLO $3.78
  • HFFG $4.93
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 38.79
  • HFFG 69.88
  • Support Level
  • ALLO $0.99
  • HFFG $2.81
  • Resistance Level
  • ALLO $1.21
  • HFFG $3.87
  • Average True Range (ATR)
  • ALLO 0.10
  • HFFG 0.21
  • MACD
  • ALLO -0.01
  • HFFG 0.11
  • Stochastic Oscillator
  • ALLO 20.59
  • HFFG 86.82

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

Share on Social Networks: